Published in Cancer Weekly, June 10th, 2008
The Company's shares were formerly traded on the OTC Bulletin Board under the ticker symbol RXHN.
"As we continue to aggressively pursue our clinical development efforts, our listing on the AMEX will increase shareholder value and provide expanded...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.